"North Carolina Halts Funding for Obesity Medications Due to Wegovy Expenses"

1 min read
Source: The New York Times
"North Carolina Halts Funding for Obesity Medications Due to Wegovy Expenses"
Photo: The New York Times
TL;DR Summary

North Carolina's state employees will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound starting April 1, as the state's health plan board voted to end all coverage of medications for weight loss due to ballooning costs, with medications like Wegovy alone costing the plan $100 million last year. This decision comes after a sharp criticism from the state treasurer, Dale Folwell, who accused Novo Nordisk of price gouging on Wegovy.

Share this article

Reading Insights

Total Reads

0

Unique Readers

10

Time Saved

1 min

vs 2 min read

Condensed

76%

31575 words

Want the full story? Read the original article

Read on The New York Times